RBC
IBB icon

Rye Brook Capital’s iShares Biotechnology ETF IBB Stock Holding History

Rye Brook Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,270
Closed -$3.5M – 28
2025
Q3 		$3.5M Sell
24,270
-30
-0.1% -$4.09K 1.82% 11
2025
Q2 		$3.07M Buy
24,300
+2,800
+13% +$344K 3.21% 10
2025
Q1 		$2.75M Buy
21,500
+200
+0.9% +$27.1K 3.45% 11
2024
Q4 		$2.82M Buy
+21,300
New +$2.99M 3.38% 10
2024
Q3 		– Sell
-19,300
Closed -$2.65M – 22
2024
Q2 		$2.65M Sell
19,300
-21,100
-52% -$2.82M 3.48% 12
2024
Q1 		$5.54M Buy
40,400
+400
+1% +$54.6K 3.25% 12
2023
Q4 		$5.43M Sell
40,000
-900
-2% -$110K 2.78% 13
2023
Q3 		$5M Buy
40,900
+100
+0.2% +$12.7K 3.56% 9
2023
Q2 		$5.18M Buy
40,800
+700
+2% +$90.9K 2.45% 7
2023
Q1 		$5.18M Buy
40,100
+50
+0.1% +$6.54K 3.17% 8
2022
Q4 		$5.26M Sell
40,050
-200
-0.5% -$25.8K 3.41% 7
2022
Q3 		$4.71M Sell
40,250
-56,090
-58% -$6.97M 3.44% 7
2022
Q2 		$11.3M Buy
96,340
+1,300
+1% +$154K 6.9% 5
2022
Q1 		$12.4M Buy
95,040
+100
+0.1% +$13K 4.89% 5
2021
Q4 		$14.5M Buy
94,940
+27,400
+41% +$4.24M 3.71% 5
2021
Q3 		$10.9M Buy
67,540
+3,600
+6% +$606K 7.68% 3
2021
Q2 		$10.5M Buy
63,940
+15,000
+31% +$2.31M 7.4% 4
2021
Q1 		$7.37M Buy
48,940
+9,100
+23% +$1.45M 5.37% 9
2020
Q4 		$6.04M Buy
+39,840
New +$5.69M 5.26% 8

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rye Brook Capital's IBB Position: Q4 2025 in Review

Rye Brook Capital sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 24,270 shares — an estimated $3.5M sold.

Rye Brook Capital first reported a position in IBB in Q4 2020 and held it in 19 quarters. The position peaked at $14.5M in Q4 2021. 957 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Rye Brook Capital reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • Rye Brook Capital sold 24,270 iShares Biotechnology ETF shares in Q4 2025, an estimated $3.5M.
  • Rye Brook Capital first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 19 quarters.
  • Rye Brook Capital's iShares Biotechnology ETF position peaked at $14.5M in Q4 2021.
  • 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Rye Brook Capital's 13F filing for Q4 2025, filed 27 Jan 2026.